CanadaViazen Immunity capsules by Distripharm Inc. (NPN 80104797), lot 242811IMN, are affected. The product was recalled because the selenium content is out of specification; owners should verify if their product is the affected lot, consult their healthcare provider before discontinuing use or for health concerns, contact Distripharm Inc. with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Distripharm Inc., 1440-100 Hocquart,, St-Bruno, QC,, J3V 6E1.
How to identify it
Brand: Viazen Immunity; Product Name: Viazen Immunity; Market Authorization: NPN 80104797; Dosage Form: Capsules; Strength: Astragalus membranaceus (140.0 mg), Camellia sinensis (50.0 mg), Ganoderma lucidum (140.0 mg), Selenium (75.0 mcg), Vaccinium angustifolium (25.0 mg), Zinc (25.0 mg); Lot: 242811IMN
The hazard
The (selenium) content is out of specification in the affected batch.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)